14385-15-0 Usage
Uses
Used in Pharmaceutical Research:
Cyclopropanecarboxamide, N-(4-chlorophenyl)-N-hydroxy-, is used as a pharmaceutical intermediate for the development of new therapeutic agents. Its unique chemical structure and potential biological activity make it a valuable compound for further research and investigation in the field of medicine.
Used in Cancer Treatment Research:
In the field of oncology, Cyclopropanecarboxamide, N-(4-chlorophenyl)-N-hydroxy-, is being studied for its potential as a therapeutic agent against various types of cancer. Its specific chemical properties may allow it to target and inhibit cancer cells, making it a promising candidate for the development of novel cancer treatments.
Used in Drug Development:
As a pharmaceutical intermediate, Cyclopropanecarboxamide, N-(4-chlorophenyl)-N-hydroxy-, plays a crucial role in the synthesis of new drugs. Its unique structure and potential biological activity can be leveraged to create innovative medications with improved efficacy and safety profiles.
Used in Medical Diagnostics:
Cyclopropanecarboxamide, N-(4-chlorophenyl)-N-hydroxy-'s specific chemical properties may also make it useful in the development of diagnostic tools and imaging agents. Its potential to interact with biological systems could be harnessed to create new methods for detecting and monitoring diseases, including cancer.
Check Digit Verification of cas no
The CAS Registry Mumber 14385-15-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,3,8 and 5 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 14385-15:
(7*1)+(6*4)+(5*3)+(4*8)+(3*5)+(2*1)+(1*5)=100
100 % 10 = 0
So 14385-15-0 is a valid CAS Registry Number.
14385-15-0Relevant articles and documents
An unusual case of carbon-nitrogen bond formation. Reactivity of a C-nitroso group toward acyl chlorides
Pilepi?, Viktor,Lovrek, Monika,Viki?-Topi?, Dra?en,Ur?i?, Stanko
, p. 8519 - 8522 (2001)
Acyl chlorides react with nitrosobenzene in 99.9% acetonitrile and in the presence of catalytic amounts of HCl giving the corresponding N-p-chlorophenylhydroxamic acids. The spectroscopic and kinetic evidence obtained indicates that the reaction is initia
Synthesis, X-ray crystal structure study, and cytostatic and antiviral evaluation of the novel cycloalkyl-N-aryl-hydroxamic acids
Barbari?, Monika,Ur?i?, Stanko,Pilepi?, Viktor,Zorc, Branka,Hergold-Brundi?, Antonija,Nagl, Ante,Grdi?a, Mira,Paveli?, Kre?imir,Snoeck, Robert,Andrei, Graciela,Balzarini, Jan,De Clercq, Erik,Mintas, Mladen
, p. 884 - 887 (2005)
In vitro evaluation of the novel cycloalkyl-N-(4-chlorophenyl)-hydroxamic acids (2a-g) demonstrated that 2b,d,e exhibited rather marked inhibitory activity (IC50 = 7-10 μM) against pancreatic carcinoma, 2b-d against colon carcinoma, 2d against
